Literature DB >> 26105212

Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion.

Monica Cabrero1, Yiting Yu2, Amit Verma2, Hui Yang1, Simona Colla1, Yu Jia1, Hong Zheng1, Zach Bohannan1, Irene Ganan-Gomez1, Andrew Futreal3, Koichi Takahashi1, Lynda Chin3, Hagop Kantarjian1, Andrea Pellagatti4, Teresa Bowman2, Jacqueline Boultwood4, Guillermo Garcia-Manero1, Yue Wei5.   

Abstract

Entities:  

Keywords:  POT1; chronic lymphocytic leukemia; haploinsufficiency; myelodysplastic syndromes

Mesh：

Substances：

Year:  2015        PMID： 26105212      PMCID： PMC5580681          DOI： 10.1111/bjh.13574

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Telomere length in myelodysplastic syndromes.

Authors:  Dana E Rollison; P K Epling-Burnette; Jong Y Park; Ji-Hyun Lee; Hyun Park; Kristen Jonathan; Ashley L Cole; Jeffrey S Painter; Mayenha Guerrier; Johana Meléndez-Santiago; William Fulp; Rami Komrokji; Jeffrey Lancet; Alan F List
Journal:  Leuk Lymphoma       Date:  2011-06-03

2.  Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Authors:  Régis Peffault de Latour; Rodrigo T Calado; Marc Busson; Jeffrey Abrams; Nadir Adoui; Marie Robin; Jérôme Larghero; Nathalie Dhedin; Alienor Xhaard; Emmanuel Clave; Dominique Charron; Antoine Toubert; Pascale Loiseau; Gérard Socié; Neal S Young
Journal:  Blood       Date:  2012-09-04       Impact factor: 22.113

3.  Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.

Authors:  Goro Sashida; Junko H Ohyashiki; Akihiro Nakajima; Masahiko Sumi; Ken Kawakubo; Tetsuzo Tauchi; Kazuma Ohyashiki
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

4.  Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.

Authors:  Ling Wu; Asha S Multani; Hua He; Wilfredo Cosme-Blanco; Yu Deng; Jian Min Deng; Olga Bachilo; Sen Pathak; Hedioshi Tahara; Susan M Bailey; Yibin Deng; Richard R Behringer; Sandy Chang
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

5.  Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.

Authors:  Simona Colla; Derrick Sek Tong Ong; Yamini Ogoti; Matteo Marchesini; Nipun A Mistry; Karen Clise-Dwyer; Sonny A Ang; Paola Storti; Andrea Viale; Nicola Giuliani; Kathryn Ruisaard; Irene Ganan Gomez; Christopher A Bristow; Marcos Estecio; David C Weksberg; Yan Wing Ho; Baoli Hu; Giannicola Genovese; Piergiorgio Pettazzoni; Asha S Multani; Shan Jiang; Sujun Hua; Michael C Ryan; Alessandro Carugo; Luigi Nezi; Yue Wei; Hui Yang; Marianna D'Anca; Li Zhang; Sarah Gaddis; Ting Gong; James W Horner; Timothy P Heffernan; Philip Jones; Laurence J N Cooper; Han Liang; Hagop Kantarjian; Y Alan Wang; Lynda Chin; Carlos Bueso-Ramos; Guillermo Garcia-Manero; Ronald A DePinho
Journal:  Cancer Cell       Date:  2015-05-11       Impact factor: 31.743

6.  Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.

Authors:  A Pellagatti; M Cazzola; A Giagounidis; J Perry; L Malcovati; M G Della Porta; M Jädersten; S Killick; A Verma; C J Norbury; E Hellström-Lindberg; J S Wainscoat; J Boultwood
Journal:  Leukemia       Date:  2010-03-11       Impact factor: 11.528

Review 7.  Telomere maintenance and human bone marrow failure.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

8.  POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.

Authors:  Andrew J Ramsay; Víctor Quesada; Miguel Foronda; Laura Conde; Alejandra Martínez-Trillos; Neus Villamor; David Rodríguez; Agnieszka Kwarciak; Cecilia Garabaya; Mercedes Gallardo; Mónica López-Guerra; Armando López-Guillermo; Xose S Puente; María A Blasco; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2013-03-17       Impact factor: 38.330

9.  Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes.

Authors:  Moritz Gerstung; Andrea Pellagatti; Luca Malcovati; Aristoteles Giagounidis; Matteo G Della Porta; Martin Jädersten; Hamid Dolatshad; Amit Verma; Nicholas C P Cross; Paresh Vyas; Sally Killick; Eva Hellström-Lindberg; Mario Cazzola; Elli Papaemmanuil; Peter J Campbell; Jacqueline Boultwood
Journal:  Nat Commun       Date:  2015-01-09       Impact factor: 14.919

10.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971
  10 in total
  1 in total

1.  Differential expression of EphA5 protein in gastric carcinoma and its clinical significance.

Authors:  Wei Zhang; Xue Wei; Shuwei Guo; Jiandong Wang; Jing Liu; Hai Wang
Journal:  Oncol Lett       Date:  2019-03-19       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.